Front cover image for Goodman & Gilman's the pharmacological basis of therapeutics

Goodman & Gilman's the pharmacological basis of therapeutics

Laurence L. Brunton (Editor), Randa Hilal-Dandan (Editor), Björn C. Knollmann (Editor)
"Goodman & Gilman's: The Pharmacological Basis of Therapeutics, Thirteenth Edition represents the pinnacle of authority and accuracy in describing the actions and uses of therapeutic agents in relation to physiology and pathophysiology. Goodman & Gilman's careful balance of basic science and clinical application has guided thousands of practitioners and students to a clear understanding of the drugs essential to preventing, diagnosing, and treating disease. Enhanced by a full-colour presentation and updated to reflect all critical new developments in drug action and drug-disease interaction, the Thirteenth Edition includes more than 440 color illustrations depicting key principles and actions of specific pathways and therapeutic agents. This edition also includes new chapters on hypertension therapy, myocardial ischemia therapy, treatment of pulmonary arterial hypertension, immunostimulants and vaccines, and treatment of viral hepatitis, along with appendices on prescription order writing, patient compliance, and pharmacokinetics."--Provided by publisher
Print Book, English, 2018
Thirteenth edition View all formats and editions
McGraw-Hill Education, New York, 2018
xiii, 1419 pages : color illustrations ; 29 cm
9781259584732, 1259584739
993810322
Section I: General Principles
Section II: Neuropharmacology
Section III: Modulation of pulmonary, renal, and cardiovascular function
Section IV: Inflammation, immunomodulation, and hematopoiesis
Section V: Hormones and hormone antagonists
Section VI: Gastrointestinal pharmacology
Section VII: Chemotherapy of infectious diseases
Section VIII: Pharmacotherapy of neoplastic disease
Section IX: Special systems pharmacology. Chapter 52: General Principles of Antimicrobial Therapy
Chapter 53: Chemotherapy of Malaria
Chapter 54: Chemotherapy of Protozoal Infections: Amebiasis, Giardiasis, Trichomoniasis, Trypanosomiasis, Leishmaniasis, and Other Protozoal Infections
Chapter 55: Chemotherapy of Helminth Infections
Chapter 56: Sulfonamides, Trimethoprim-Sulfamethoxazole, Quinolones, and Agents for Urinary Tract Infections
Chapter 57: Penicillins, Cephalosporins, and Other β-Lactam Antibiotics
Chapter 58: Aminoglycosides
Chapter 59: Protein Synthesis Inhibitors and Miscellaneous Antibacterial Agents
Chapter 60: Chemotherapy of Tuberculosis, Mycobacterium avium Complex Disease, and Leprosy
Chapter 61: Antifungal Agents
Chapter 62: Antiviral Agents (Nonretroviral)
Chapter 63: Treatment of Viral Hepatitis (HBV/HCV)
Chapter 64: Antiretroviral Agents and Treatment of HIV Infection
Section VIII: Pharmacotherapy of Neoplastic Disease
Chapter 65: General Principles in the Pharmacotherapy of Cancer
Chapter 66: Cytotoxic Drugs
Chapter 67: Pathway-Targeted Therapies: Monoclonal Antibodies, Protein Kinase Inhibitors, and Various Small Molecules
Chapter 68: Hormones and Related Agents in the Therapy of Cancer
Section IX: Special Systems Pharmacology
Chapter 69: Ocular Pharmacology
Chapter 70: Dermatological Pharmacology
Chapter 71: Environmental Toxicology: Carcinogens and Heavy Metals
Appendices
Appendix I: Principles of Prescription Order Writing and Patient Compliance
Appendix II: Design and Optimization of Dosage Regimens: Pharmacokinetic Data